Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major

Archives of Iranian Medicine

Volumn 9, Issue 4, 2006, Pages 329-334

  Moayeri, Heshmat ^a   Oloomi, Zohreh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gonadotropins; Growth; Growth hormone; Puberty; Thalassemia major

Indexed keywords

CALCIUM; CLONIDINE; DEFEROXAMINE; ESTRADIOL; ETHINYLESTRADIOL; FERRITIN; FOLLITROPIN; GLUCOSE; GONADOTROPIN; GROWTH HORMONE; INSULIN; LEVODOPA; LUTEINIZING HORMONE; PHOSPHORUS; PRASTERONE SULFATE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; TESTOSTERONE ENANTATE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; BODY HEIGHT; BONE AGE; CALCIUM BLOOD LEVEL; CLINICAL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DATA COLLECTION METHOD; DEVELOPMENTAL STAGE; ENDOCRINE DISEASE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; GONADOTROPIN RELEASE; GROWTH CURVE; GROWTH DISORDER; GROWTH HORMONE RELEASE; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; IRAN; IRON CHELATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTPATIENT DEPARTMENT; PHOSPHATE BLOOD LEVEL; PREVALENCE; PUBERTY; PUBERTY DISORDERS; SCHOOL CHILD; SHORT STATURE; STATISTICAL ANALYSIS; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; CHILD; FEMALE; GONADOTROPINS; GROWTH; GROWTH HORMONE; HUMANS; MALE; PUBERTY; PUBERTY, DELAYED;

EID: 33751327095     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fosburg MT, Nathan DG. Treatment of Cooley's anemia. Blood. 1990; 76: 435-444.
2. Hoffbrand AV, Wonke B. Iron chelation therapy. J Intern Med Suppl. 1997; 740: 37-41.
3. Britton RS, Ramm GA, Olynyk J, Singh R, O'Neill R, Bacon BR. Pathophysiology of iron toxicity. Adv Exp Med Biol. 1994; 356: 239-253.
4. Grundy RG, Wood KA, Savage MO, Evans JPM. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child. 1994; 71: 128-132.
5. Anoussakis C, Alexiou D, Abatzis D, Bechrakis G. Endocrinological investigation of pituitary gonadal axis in thalassaemia major. Acta Paediatr Scan. 1977; 66: 49-51.
6. Tolis G, Politis C, Kontopoulou I, Poulatzas N, Rigas G, Saridakis C, et al. Pituitary somatotropic and corticotropic function in patients with beta-thalassemia on iron chelation therapy. Birth Defects Orig Artic Ser. 1987; 23: 449-452.
7. Sabato AR, De Sanctis V, Atti G, Capra L, Bagni B, Vullo C. Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child. 1983; 58: 120-124.
8. Costin G, Kogut MD, Hyman CB, Ortaga JA. Endocrine abnonmalities in thalassemia major. Am J Dis Child. 1979; 133: 497-502.
9. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000; 13: 651-656.
10. Costin G, Kogut MD, Hyman C, Ortega JA. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes. 1997; 26: 230-240.
11. Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V. Epidemiology and chelation therapy effects on glucose hemostasis in thalassemic patients. J Pediatr Endocrinol Metab. 1998; 11 (suppl 3): 867-869.
12. Brittenham GM, Griffith PM, Niehuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of desferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994; 331: 567-573.
13. Tanner JM, Whitehouse RH. Clinical longitudinal standards of height, weight, height velocity, and stages of puberty. Arch Dis Child. 1976; 51: 170-179.
14. Grambach MM, Styne DM. Diagnosis of delayed puberty and sexual infantilism. In: Williams RH, Larsen PR, ed. Williams Textbook of Endocrinology. 10th ed. Philadelphia: Saunders; 2003: 1196-1202.
15. Bridge N. Disorders of puberty: pubertal delay and pubertal failure. In: Brook CGD, Hindmarsh PC, eds. Clinical Pediatric Endocrinology. 4th ed. London: Blackwell Science; 2001: 173-175.
16. Dattani MT. Tests in pediatric endocrinology and normal values. In: Brook CGD, Hindmarsh PC, eds. Clinical Pediatric Endocrinology. 4th ed. London: Blackwell Science; 2001; 474-475.
17. De Sanctis V, Caruso-Nicoletti M, Pintor C, Raiola G. Guidelines for the diagnosis and treatment of endocrinopathies in thalassemia. Riv Ital Pediatr (IJP). 1999; 25: 1132-1137.
18. Raiola G, Galati MC, De Sanctis V, Caruso-Nicoletti M, Pintor C, De Simone M, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003; 16: 259-266.
19. Berkovitch M, Bistritzer T, Milone SD, Perlman K, Kucharczyk W, Olivieri NF. Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. J Pediatr Endocrinol Metab. 2000; 13: 179-184.
20. No authors listed. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin Endocrinol (Oxf). 1995; 42: 581-586.
21. Soliman AT, Elzalabany M, Armer M, Ansari BM. Growth and pubertal development in transfusion dependent children and adolescents with thalassemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999; 45: 23-30.
22. Borgna-Pignatti C, De Stefano P, Zonta L, Vullo C, De Sanctis V, Melevendi C, et al. Growth and sexual maturation in thalassemia major. J Pediatr. 1985; 106: 150-155.
23. Karagiorga-Lagana M, Papadakou-Lagoyanni S, Pantelakis S, Galati MC. Body growth in Cooley's anemia in relation to hemoglobin and ferrtin level. Latriki. 1980; 38: 38-39.
24. Caruso-Nicoletti M, De Sanctis V, Anastasi S, Cavagnini F, Pintor C. Guidelines for the auxological follow-up of thalassemic patients. Riv Ital Pediatr (IJP). 1997; 23: 305-307.
25. Leger J, Girot R, Crosnier H, Postel-Vinay MC, Rappaport R. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect. J Clin Endocrinol Metab. 1989; 69: 453-456.
26. Chatterjee R, Katz M, Cox T, Bantock H. Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test. Eur J Pediatr. 1993; 152: 721-726.
27. Soliman AT, El-Banna N, Ansari BM. GH response to provocation and circulating IGF-I and IGF binding protein 3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia. Eur J Endocrinol. 1998; 138: 394-400.
28. Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, et al. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr. 1997; 156: 777-783.
29. Shehadeh N, Hazani A, Rudolf MC, Peleg I, Benderly A, Hochberg Z. Neurosecretory dysfunction of growth hormone secretion in thalassaemia major. Acta Paediatr Scand. 1990; 79: 790-795.
30. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, et al. Depressed serum somatomedin activity in beta-thalassemia. J Pediatr. 1980; 96: 214-218.
31. Werther GA, Mathews RN, Burger HC, Herington A. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major. J Clin Endocrinol Metab. 1981; 53: 806-809.
32. De Sanotis V, Urso L, Galati MC, Mangiagli A. Growth hormone (GH) treatment in thalassemic patients with short stature, GH insufficiency, and different severity of iron overload. Bone Marrow Transplant. 1997; 19 (suppl 2): 32-33.
33. Katzos G, Papakostantinou-Athanasiadou E, Athanasiou-Metaxa M, Harsoulis F. Growth hormone treatment in short children with beta-thalassemia major. J Pediatr Endocrinol Metab. 2000; 13: 163-170.
34. Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, et al. Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab. 1998; 11: 835-844.